Commercialization: Page 63
-
SHOWCASE FEATURE: Connecting the Data Dots
Experts at Best Practices note that the current uncertain global economy has accentuated life-sciences executives’ need for powerful market insights to gain an edge over competitors. These companies are increasingly challenged to transform their market research departments from backward-looking s...
By Carolyn Gretton • Feb. 27, 2012 -
Pharma 3.0
As the industry evolves to address a new ecosystem within the complex and global drug development and commercialization arena, companies will need to be open to using new technologies, thinking, and processes to make healthcare more sustainable, affordable, and accessible; improve the efficiency ...
By PharmaVoice Team • Feb. 26, 2012 -
Final Phase Goal: Maximize Uptake While Speeding to Launch
In every phase of drug development today, processes are more complex and more costly than ever and the drive to reduce time and expenditure is more critical. In today’s ever-changing marketplace, this holds true especially for the last stages of the process: registration, launch, and postlaunch. ...
By PharmaVoice Team • Feb. 26, 2012 -
Talent Pool
Pharmaceutical POOL Dr. Anders EKBLOM Dr. Briggs MORRISON AstraZeneca Bolsters R&D Leadership Global pharmaceutical company AstraZeneca has tapped Anders Ekblom, M.D., to build and lead the science and technology integration office within the company’s R&D organization. In addition to th...
By Carolyn Gretton • Feb. 26, 2012 -
Social Media
Social Media Trends, Regs, and Apps Featured Briefs: Government Use of Social Media Grows First-Ever Tweet From a President Garners More Than 20,000 Responses Survey: Consumers Favor Pharma Input in Patient Communities Industry Gets More Time to Adhere to New YouTube Format TECH CHECK Apps, Twe...
By Robin Robinson • Feb. 26, 2012 -
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Healogix Unveils Adaptive Toolbox Solution Group DCA Enhances Digital Detailing Solution In other technology news… E-UPGRADES AND ENHANCEMENTS Healthcare companies have struggled for years to understand how and w...
By Carolyn Gretton • Feb. 26, 2012 -
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Long-Term Planning Tactics Key to Maintaining Portfolio Health Sidebar: Groups Responsible for Aligning Brand and Corporate Strategy Therapeutic Fast Trax… Other market insights… Brand Positioning Should Balance PR, RO...
By Taren Grom • Feb. 26, 2012 -
UpFront
Awards… » Invivodata Co-Founder wins Carnegie Science Awards Invivodata Co-founder and Chief Science Officer, Dr. Saul Shiffman has been recognized by the Carnegie Science Center as an honorable mention in the Entrepreneur Category of its 2012 Carnegie Science Awards. Dr. Shiffman is being ...
By Taren Grom • Feb. 26, 2012 -
Letter from the Editor
From Molecule through Market… the vision is clear — to be successful pharmaceutical companies and their valued development partners need to understand the underlying challenges, trends, and opportunities that each molecule, compound, diagnostic, or biotech product faces as it progresses along the...
By Taren Grom • Feb. 26, 2012 -
Outsourcing: Enhance, Support, Grow
You cannot do today’s job with yesterday’s methods and be in business tomorrow." The wise words of Nelson Jackson should be the driving force behind every outsourcing partnership today. Implementing innovative strategies through outsourcing helps pharmaceutical companies meet the changing demands...
By Erin Neary and Dennis McLoughlin • Jan. 27, 2012 -
Commercialization - Decisions, Decisions, Decisions
In recent years, the research and development landscape in the pharmaceutical industry has radically changed. The search for the next big blockbuster has been replaced by the search for medicines targeted toward specific patient subpopulations or toward diseases with high unmet medical need to ma...
By Dr. Michael Ackerman • Jan. 27, 2012 -
Pharmaceutical Call Centers Build relationships with Healthcare Providers and Patients
Pharmaceutical, biotechnology, and medical device companies have a significant need to build relationships with prescribers and patients. However, these audiences have very different needs that require companies to take varying approaches to communicate effectively with them. Healthcare providers...
By Lou Shapiro • Jan. 27, 2012 -
The Emergence of Strategic Outsourcing in Clinical Supply Chain Management
Ten years ago few biopharmaceutical industry professionals could have predicted how broadly the landscape for outsourcing would change by 2012. Most companies were outsourcing in a tactical, project-by-project manner and utilizing dozens of providers across functional areas. Some were moving to a...
By Robert Dunlop • Jan. 27, 2012 -
Why Outsourcing Patient Enrollment to a Specialist Makes Sense
Richard Malcolm, Ph.D., CEO, Acurian Disruptive change is needed in clinical trial management, an industry where inadequate enrollment has become the biggest driver of wasted dollars. The cost of patient enrollment is now the single largest part of the total trial budget, representing 32% of the ...
By Richard Malcolm • Jan. 27, 2012 -
SHOWCASE FEATURE: Help from The Outside
Help from the Outside Showcase Feature: Outsourcing Carolyn Gretton As life-sciences companies look to improve operational efficiencies within their organizations, they are increasingly reducing the number of activities that they would categorize as core competencies and outsourcing them to thir...
By Carolyn Gretton • Jan. 27, 2012 -
Trends, Challenges, and Best Practices of Global Product Launches
Companies both large and small are expanding their global launch approach. Robin Robinson With all the variances and complexities involved in launching a product globally, especially around regulatory and approval requirements within various regions across countries, one could argue that there is...
By Robin Robinson • Jan. 27, 2012 -
C-Suite CROs
Insights from the C-Suite: Contract Research Organizations CRO growth continues to outpace other sectors. Frost &?Sullivan estimates that the CRO market earned revenue of $11.43 billion in 2010 and estimates that the sector will top $20.09 billion in 2017. According to a recent Frost & Su...
By Taren Grom • Jan. 27, 2012 -
Digital Patient-Centric Communications: Listen and Learn
Learning to listen and listening to learn are critical to a successful social networking marketing plan. While the buzzword in marketing these days is patient-centric, the industry still struggles with shifting its focus from products to consumers. Years of pushing product messaging out into the ...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn Gretton Life-Sciences Companies Face Increased Complexity in Aggregate Spend Tracking and Reporting Trend: Aggregate spend mandates within the life-sciences industry are continuing to evolve in 2012 amid ongoing cha...
By Carolyn Gretton • Jan. 27, 2012 -
Social Media
Social Media trends, regs, and apps By Robin Robinson Palio Launches Wiki for Healthcare and Pharmaceutical Apps Trend Watch: Use of wikis to monitor social media activity spreads to apps. Our PharmApps wiki gives users the ability to comment, write a review, rate apps, share, and upload new app...
By Robin Robinson • Jan. 26, 2012 -
Tools of the Trade
New electronic and web-based applications, sites, and technologies By Carolyn Gretton New Tool from HRM Aims to Improve Medication Adherence, Patient Outcomes Trend: A growing number of healthcare providers are using intuitive technological tools to connect directly with patients to provide info...
By Carolyn Gretton • Jan. 26, 2012 -
UpFront
INDUSTRY at Large Milestones… Spectrum Celebrates 15 Years Spectrum, a health and science communications agency, is celebrating its 15th anniversary. The independent agency, which was founded by John Seng in 1996, is committed to achieving the goals of clients who are involved with issues, pro...
By Taren Grom • Jan. 26, 2012 -
Letter from the Editor
New commercial models paying dividends… Creating value — the goal for all companies — and how they achieve this goal are as different as the companies themselves. According to a recent report — Strength in the Storm: How Biopharmaceutical and Medical Technology Companies Can Create Value in a Cha...
By Taren Grom • Jan. 26, 2012 -
Healthcare Decisions in the Age of Social Networks: The Facts About Influencers, Trust and Privacy
Clearly, social networks are an integral part of our lives today. But how much do they impact healthcare decisions? Do people trust — and act on — what they read online? To find out, SSI conducted a study with more than 1,450 U.S. consumers 13 and older. About half of our respondents are from our...
By Chris Deangelis • Dec. 22, 2011 -
Search and Social Media for the Pharmaceutical Industry
Much has been said about the role of social media as a marketing vehicle. It offers customers and audiences a way to interact with brands like never before. The paradigm of audience has shifted as our “push" messaging has evolved to a conversation. In the pharmaceutical industry, we are looking t...
By Christopher Cullman • Dec. 22, 2011